(S)-2-Amino-5-guanidinopentanoic acid 2-hydroxysuccinic acid (1:x)

Catalog No. :
ACVFLU311
CAS No. :
41989-03-1
Molecular Formula :
C10H20N4O7
Molecular Weight :
308.29

IUPAC Name:(S)-2-amino-5-((diaminomethylene)amino)pentanoic acid--2-hydroxysuccinic acid (1/1)

(S)-2-Amino-5-guanidinopentanoic acid 2-hydroxysuccinic acid (1:x) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g98%$367.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-Amino-5-guanidinopentanoic acid 2-hydroxysuccinic acid (1:x)
IUPAC Name(S)-2-amino-5-((diaminomethylene)amino)pentanoic acid--2-hydroxysuccinic acid (1/1)
Molecular FormulaC10H20N4O7
Molecular Weight308.29
SMILESO=C(O)[C@@H](N)CCCNC(N)=N.O=C(O)C(O)CC(O)=O
InChI KeyRUFJTBOKWJYXPM-WCCKRBBISA-N
SynonymL-arginine malate;Arginine malate;(S)-2-Amino-5-guanidinopentanoic acid 2-hydroxysuccinic acid (1:1);(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid,2-hydroxybutanedioic acid;Arginine malate USP/EP/BP;L- Arginine Malate USP/EP/BP;L-Arginine,compounds,hydroxybutanedioate;(s)-2-Amino-5-((diaminomethylene)amino)pentanoic acid compound with 2-hydroxysuccinic acid (1:1)
CAS No.41989-03-1

Synthetic Route by SureRoute

1. ACVFLU311 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEPXS502 route compound structure diagram
    ACEPXS5025408-52-6 In Stock
  4. Then
  5. ACVFLU311 route product structure diagram
    ACVFLU31141989-03-1
Inquiry

2. ACVFLU311 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIVZM995 route compound structure diagram
    ACIVZM995345909-32-2 In Stock
  2. Plus
  3. ACDQFU091 route compound structure diagram
    ACDQFU09156-89-3 In Stock
  4. Then
  5. ACVFLU311 route product structure diagram
    ACVFLU31141989-03-1
Inquiry

Comments (0)